叔戊酰基肉碱 | 98299-38-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 叔戊酰基肉碱
• 中文别名: 6-氨基-4-甲基-2H-色烯-2-酮
• 英文名称: Pivaloylcarnitine
• 英文别名: 3-(2,2-dimethylpropanoyloxy)-4-(trimethylazaniumyl)butanoate
• CAS: 98299-38-8
• 化学式: C12H23NO4
• 分子量: 245.32
• InChiKey: YICAQFPUDACYGQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  17
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  66.4
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• LABELLED CARBOXYLIC ACIDS AND THEIR USES IN MOLECULAR IMAGING
  申请人：Imperial Innovations Limited

  公开号：US20160095946A1

  公开（公告）日：2016-04-07

  The present invention pertains generally to the field of imaging compounds, and more specifically to certain 2,2-dialkyl radionuclide-labelled carboxylic acids suitable for PEWT, SPECT and/or DNP imaging. Also described are uses of such compounds in the imaging of, inter alia, cancer tumors, metastasis, Alzheimer's disease and multiple sclerosis.

  本发明一般涉及成像化合物领域，更具体地涉及某些适用于PET、SPECT和/或DNP成像的2,2-二烷基放射性标记的羧酸。还描述了这些化合物在成像癌瘤、转移、阿尔茨海默病和多发性硬化等方面的用途。
• A pharmaceutical preparation comprising an acylcarnitine
  申请人：Kuratsune, Hirohiko

  公开号：EP0681839A2

  公开（公告）日：1995-11-15

  A pharmaceutical preparation comprising an acylcarnitine or a pharmacologically acceptable salt thereof is administered orally or parenterally to treat or prevent a symptom caused by acylcarnitine metabolic dysfunction. The acylcarnitine may be acetylcarnitine, propionylcarnitine, butyrylcarnitine, isobutyrylcarnitine, valerylcarnitine, isovalerylcarnitine, hexanoylcarnitine and so on.

  口服或肠外给药包含酰基肉碱或其药理学上可接受的盐的药物制剂，用于治疗或预防酰基肉碱代谢功能障碍引起的症状。酰基肉碱可以是乙酰肉碱、丙酰肉碱、丁酰肉碱、异丁酰肉碱、戊酰肉碱、异戊酰肉碱、己酰肉碱等。
• Labelled acyl-L-carnitine and diagnostic agent
  申请人：Japan Science and Technology Corporation

  公开号：EP0770400A2

  公开（公告）日：1997-05-02

  The present invention provides a labelled acyl-L-carnitine, which is an acyl-L-carnitine, a salt thereof or a derivative thereof, of which carbon group is labelled with a radionuclide or a stable isotope. It is possible to diagnose human diseases falling under acyl-carnitine metabolic syndrome, or human diseases due to structural/functional disorder of the brain by measuring the behavior of the labelled acyl-L-carnitine in various tissues or a biological sample from a subject administered with one or more kinds of the labelled acyl-L-carnitines.

  本发明提供了一种标记的酰基-L-肉碱，它是一种酰基-L-肉碱、其盐或其衍生物，其碳基被放射性核素或稳定同位素标记。通过测量被标记的酰基-L-肉碱在各种组织或生物样本中的表现，可以诊断属于酰基-L-肉碱代谢综合征的人类疾病，或由于大脑结构/功能紊乱引起的人类疾病。
• METABOLIC SIGNATURE AND USE THEREOF FOR THE DIAGNOSIS OF GLAUCOMA
  申请人：Université d'Angers

  公开号：EP3546938A1

  公开（公告）日：2019-10-02

  The present invention relates to a metabolic signature comprising at least four metabolites selected from the group comprising arginine, butyrylcarnitine (C4), decenoylcarnitine (C10:1), dodecenoylcarnitine (C12:1), hexoses, histamine, methionine, methionine sulfoxide, octadecenoylcarnitine (C18:1), octadecadienoylcarnitine (C18:2), PC aa 34:2, PC aa 34:4, PC aa 36:4, PC ae 40:1, propionylcarnitine (C3), spermidine, spermine and tyrosine, wherein said metabolic signature is indicative of glaucoma in a subject. The present invention also relates to a method for diagnosing glaucoma in a subject and/or for identifying a subject as being at risk for glaucoma. The present invention also relates to a method for diagnosing glaucoma in a subject and/or for identifying a subject as being at risk for glaucoma. The present invention also relates to a kit for implementing the method of the invention.

  本发明涉及一种代谢特征，它包含至少四种代谢物，这些代谢物选自精氨酸、丁酰肉碱（C4）、癸烯酰肉碱（C10:1）、十二碳酰肉碱（C12:1）、己糖、组胺、蛋氨酸、蛋氨酸亚砜、十八碳酰肉碱（C18：1）、十八碳二烯酰基肉碱（C18:2）、PC aa 34:2、PC aa 34:4、PC aa 36:4、PC ae 40:1、丙酰肉碱（C3）、亚精胺、精胺和酪氨酸，其中所述代谢特征表明受试者患有青光眼。本发明还涉及一种诊断受试者青光眼和/或确定受试者青光眼风险的方法。本发明还涉及一种诊断受试者青光眼和/或确定受试者青光眼风险的方法。本发明还涉及一种用于实施本发明方法的试剂盒。
• Labelled carboxylic acids and their uses in molecular imaging
  申请人：Cancer Research Technologies Limited

  公开号：US10821194B2

  公开（公告）日：2020-11-03

  The present invention pertains generally to the field of imaging compounds, and more specifically to certain 2,2-dialkyl radionuclide-labelled carboxylic acids suitable for PET, SPECT and/or DNP imaging. Also described are used of such compounds in the imaging of inter alia, cancer tumours, metastasis, Alzheimer's disease and multiple sclerosis.

  本发明一般涉及成像化合物领域，更具体地说，涉及某些适用于 PET、SPECT 和/或 DNP 成像的 2,2-二烷基放射性核素标记羧酸。本发明还描述了此类化合物在癌症肿瘤、转移、老年痴呆症和多发性硬化症等成像中的应用。